We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. In simpler terms, it measures the profitability of a company in relation to ...

“(We) got together and said we need intervention to fill the gap,” said Marla Schneider, President/CEO of GMED. “We do need a full-time person here to help move housing forward, we believe that’s our ...

On Wednesday, Globus Medical Inc (GMED) stock saw a modest uptick, ending the day at $75.07 which represents a slight increase of $0.78 or 1.05% from the prior close of $74.29. The stock opened at $74 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Detailed price information for Dupont Denemours Inc (DD-N) from The Globe and Mail including charting and trades.

Quest Diagnostics Inc.’s DGX third-quarter revenue growth can be attributed to the strong momentum in its expanding portfolio ...

Boston Scientific BSX is gaining traction in the international markets. New regulatory approvals and accretive acquisitions ...

Buy GMED near 74.77 target 80.28 stop loss @ 74.55 Details The technical summary data tells us to buy GMED near 74.77 with an upside target of 80.28. This data also tells us to set a stop loss @ 74.55 ...